ERIS

Eris Lifesciences Ltd operates in the pharmaceutical industry in India, focusing on the manufacture and marketing of domestic pharmaceutical formulations. The company’s portfolio includes products in cardiology, diabetes, gastroenterology, dermatology, as well as medical aesthetics and injectables. Its business model centers on a pure-play domestic formulations strategy supported by a field force that engages with super-specialist and specialist doctors. Eris Lifesciences has established a strong market position in the chronic segment, which constitutes a significant portion of its revenue. There is no publicly available information regarding its incorporation year, founders, key management, subsidiaries, or stock exchange listings.